Insider Stock Trading History of Bishop Hans Edgar


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bishop Hans Edgar since year 2005. The trader's CIK number is 1480212. At the time of this reporting, Bishop Hans Edgar is the CEO & President of Juno Therapeutics, Inc. . (stock ticker symbol JUNO). See this page for all insider trading activities at Juno Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Bishop Hans Edgar since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-16 JUNO Juno Therapeutics, Inc. Sale 270,250 46.61 12,595,271
2018-01-16 JUNO Juno Therapeutics, Inc. Option Ex 245,750 6.36 1,562,970
2016-09-27 JUNO Juno Therapeutics, Inc. Option Ex 44,000 6.36 279,840
2016-09-27 JUNO Juno Therapeutics, Inc. Sale 44,000 33.00 1,452,000
2016-09-20 JUNO Juno Therapeutics, Inc. Option Ex 6,300 6.36 40,068
2016-09-19 JUNO Juno Therapeutics, Inc. Option Ex 428 6.36 2,722
2016-09-21 JUNO Juno Therapeutics, Inc. Sale 77,307 30.30 2,342,556
2016-09-20 JUNO Juno Therapeutics, Inc. Sale 6,300 30.00 189,006
2016-09-19 JUNO Juno Therapeutics, Inc. Sale 428 30.00 12,840
2016-09-21 JUNO Juno Therapeutics, Inc. Option Ex 6,057 6.36 38,522
2016-09-08 JUNO Juno Therapeutics, Inc. Sale 23,042 30.06 692,573
2016-09-08 JUNO Juno Therapeutics, Inc. Option Ex 23,042 6.36 146,547
2016-08-31 JUNO Juno Therapeutics, Inc. Option Ex 18,173 6.36 115,580
2016-08-31 JUNO Juno Therapeutics, Inc. Sale 42,673 30.05 1,282,537
2016-06-30 JUNO Juno Therapeutics, Inc. Option Ex 44,000 6.36 279,840
2016-06-09 JUNO Juno Therapeutics, Inc. Sale 90,750 47.38 4,300,098
2016-06-09 JUNO Juno Therapeutics, Inc. Option Ex 54,000 6.36 343,440
2016-02-29 JUNO Juno Therapeutics, Inc. Option Ex 54,000 6.36 343,440
2016-02-29 JUNO Juno Therapeutics, Inc. Sale 90,750 35.86 3,254,476
2015-12-15 JUNO Juno Therapeutics, Inc. Option Ex 54,000 6.36 343,440
2015-12-15 JUNO Juno Therapeutics, Inc. Sale 91,500 45.72 4,183,014

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bishop Hans Edgar (CEO & President of Juno Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.